146 related articles for article (PubMed ID: 417377)
1. Clinical and plasma level characteristics of intramuscular and oral loxapine.
Simpson GM; Cooper TB; Lee JH; Young MA
Psychopharmacology (Berl); 1978 Mar; 56(2):225-32. PubMed ID: 417377
[TBL] [Abstract][Full Text] [Related]
2. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Tuason VB
J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
[TBL] [Abstract][Full Text] [Related]
3. Rapid tranquilization: a comparison of thiothixene with loxapine.
Dubin WR; Weiss KJ
J Clin Psychiatry; 1986 Jun; 47(6):294-7. PubMed ID: 3711026
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
Wittkopp TA
J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Paprocki J; Versiani M
Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
[No Abstract] [Full Text] [Related]
6. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
[No Abstract] [Full Text] [Related]
7. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
[No Abstract] [Full Text] [Related]
8. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
Simpson GM; Cuculic Z
J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
Kiloh LG; Williams SE; Grant DA; Whetton PS
J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
Moyano CZ
Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
[TBL] [Abstract][Full Text] [Related]
11. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Tuason VB; Escobar JI; Garvey M; Schiele B
J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
[TBL] [Abstract][Full Text] [Related]
12. [Loxapine succinate: a new neuroleptic].
Cottereau MJ; Poirier MF; Lôo H; Deniker P
Encephale; 1979; 5(3):251-67. PubMed ID: 39739
[TBL] [Abstract][Full Text] [Related]
13. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
Schiele BC
Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute psychotic patients with loxapine parenterally.
Fruensgaard K; Jensen K
Curr Ther Res Clin Exp; 1976 Feb; 19(2):164-9. PubMed ID: 813953
[No Abstract] [Full Text] [Related]
15. Efficacy of loxapine in the treatment of paranoid schizophrenia.
Bishop MP; Simpson GM; Dunnett CW; Kiltie H
Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
[TBL] [Abstract][Full Text] [Related]
16. Loxapine concentrate in acute schizophrenia.
O'Connell RA; Jeewa M; Allen K
Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
[No Abstract] [Full Text] [Related]
17. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia.
Clark ML; Paredes A; Costiloe JP; Fulkerson FG; Wood F
Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984
[TBL] [Abstract][Full Text] [Related]
18. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
Selman FB; McClure RF; Helwig H
Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
[No Abstract] [Full Text] [Related]
19. Determination of loxapine in human plasma and urine and identification of three urinary metabolites.
Cooper SF; Dugal R; Bertrand MJ
Xenobiotica; 1979 Jul; 9(7):405-14. PubMed ID: 494666
[TBL] [Abstract][Full Text] [Related]
20. Loxapine in newly admitted chronic schizophrenic patients.
Clark ML; Paredes A; Costiloe JP; Wood F; Barrett A
J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):286-94. PubMed ID: 1092725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
